Pinned Tweet
You have found it! Your source for 🆓CE/CME via Twitter! Each program provides 0.5h credit for #physicians, #pharmacists, and #nurses on #IBD. Expert authors! See archived programs at academiccme.com/ibd-twitter.
1
49
33) @SagarLonialMD adds: This is a very important study, the 1st randomized demonstration that #CELMoDs can partner well w/other agents & demonstrates superior #PFS vs a standard control arm. The 18mo #PFS for a relatively simple tx delivery process ➡️a great new option for pts.
31) Safety was consistent w/prior #Mezi data; no new signals. Most common grade 3/4 AE: #neutropenia (61.1%), manageable with dose modifications and/or G-CSF; only 1 pt discontinued due to it. Importantly, most infections were NOT associated with grade 3/4 neutropenia. #ASCO2026
28) The #PFS benefit was consistent across ALL prespecified subgroups, regardless of age, #ISS stage, #cytogenetic risk, refractory status (anti-CD38, #LEN, or both), number of prior LOTs, or presence of extramedullary disease. No subgroup favored Kd.
#ASCO2026 #SUCCESSOR2
22) Why does this trial matter? More #MM pts arrive at relapse already exposed to anti-CD38 mAbs AND lenalidomide. That dual exposure carries a median PFS of just 6.3 mo, so highly effective, convenient options for these pts are urgently needed. #ASCO2026 #SUCCESSOR2
21b) ... as it is in #SUCCESSOR_2 (where the #proteasome inhibitor #PI is #carfilzomib), but in other trials it is combined with the PI #bortezomib, or in a triplet regimen with #daratumumab.
21a) As shown, both drugs are being actively studied in #RRMM; #Iberdomide in combo with #daratumumab, a targeted monoclonal antibody #MAb used to treat #MM & #AL_amyloidosis.
#Mezigdomide is primarily used in combo with dexamethasone & a proteasome inhibitor ...
19) Your faithful correspondent and #MM expert faculty @SagarLonialMD was in the room at #ASCO26 on behalf of @onc_ce as Paul G. Richardson, MD (@DanaFarber) presented the Ph 3 #SUCCESSOR_2 primary analysis!
17) Early clinical data with #mezigdomide+#dexamethasone in triple-class-refractory #RRMM showed an ORR of 40.6%, median PFS of 4.4 months, & median DOR of 7.6 months, with neutropenia & infection among the key toxicities.
🔓 pubmed.ncbi.nlm.nih.gov/3764…
Check out this 🆓webinar from founding @ibd_ce faculty @GI_PharmD on June 27. Presented by @ASHPOfficial and you can register now at https://nitter.cf/t.co/0wrErFLWne. Don't miss it!
1
129
ibd_ce retweeted
☯️Passionate about #IBD & #InterventionalEndoscopy?
This🔥@ASGEendoscopy course #InterventionalIBD led by @SchairerIBDMD @GKochharMD is 4 you!
✅Stricture Dilation, Stricturotomy, Stenting
✅EUS
✅Fistula endo Rx
& more
🔗https://nitter.cf/t.co/V6eFzScLm6
In person/💻
Didactic/hands-on
Enhance care of IBD patients with endoscopy at Interventional IBD, June 16-17! This includes learning advanced endoscopic techniques to care for IBD patients such as balloon dilation, stricturotomy and enteral stenting: https://nitter.cf/t.co/bq2vLbES3T #GITwitter #IBD #Endoscopy
ibd_ce retweeted
📣 Looking for #CE, #CME credit?
✅ Out this #tweetorial on #IBD and #biosimilars! Had a great time putting this together with @academiccme @AmanRheumPharm and Dr. Cheiftez!
1a) Welcome to our first ever joint #accredited #tweetorial on @ibd_ce! You may know us from @cardiomet_ce or @ckd_ce or @onc_ce. We bring expert-authored 🆓CE/#CME to you wholly on Twitter, in a fun and bite-sized exchange. Follow us!
ibd_ce retweeted
There are simply too many diseases which can cause abdominal discomfort and change in bowel habits without any obvious endoscopic or radiologic findings.
Without a heavy focus on biomarker development to subdivide IBS, the field will not advance dramatically in future.
#IBSAwarenessMonth
ibd_ce retweeted
Excellent initiative to start this peer-reviewed, open access, journal by Canadian IBD clinicians. Thanks to the editorial board @TBessissow @GI_JeffMD @SeowCynthia @RPanaccione and the generous support from @TakedaPharma
canadianibdtoday.com/
ibd_ce retweeted
Last year news, but not sure we IBD community captured this: Adalimumab beneficial as add-on in pilot RCT of major depression pts. Similar signal with IFX before. Should pts with IBD+depression get aTNF as 1st line?
journals.lww.com/clinicalneu…




























